AFL: Future Performance Will Reflect Claims Tailwinds And Balanced Capital Return Execution

Analysts have modestly raised their price targets on Aflac, with recent upward revisions ranging from approximately $5 to $6 per share. They cite better than expected life insurance earnings, favorable claims experience, and resilient earnings trends despite macro uncertainties.

Analyst Commentary

Recent research notes point to a generally constructive view on Aflac, with modestly higher price targets reflecting confidence in the companys earnings durability and capital deployment, while still acknowledging pockets of macro and sector risk.

Bullish Takeaways

Bullish analysts highlight that life insurance earnings have consistently exceeded what recent share price moves would imply, suggesting upside risk to consensus estimates and supporting higher valuation multiples.
Favorable claims experience in both life and supplemental lines is seen as a structural tailwind for underwriting margins, underpinning expectations for stable to improving return on equity.
Some analysts point to calmer catastrophe activity in Q3 and limited macro spillover into earnings as evidence that Aflac can execute through volatility, reinforcing confidence in mid single digit earnings growth.
Views that investment income normalization, additional fee days, and equity market tailwinds will continue to support top line and earnings are factored into higher price targets and reiteration of positive ratings.

Bearish Takeaways

Bearish analysts caution that much of the benefit from normalized investment income and fee tailwinds is already well understood, limiting further re rating potential from these drivers alone.
There is concern that secular flow headwinds and competitive dynamics could temper growth in certain fee based businesses, introducing execution risk to out year targets.
Sector commentary around a softening property and casualty cycle heading into 2026 raises questions about broader insurance sector multiples and could indirectly weigh on sentiment for Aflac.
With shares closer to revised price targets, some see a more balanced risk reward profile near term, arguing that incremental upside will depend on continued positive surprises in claims and capital returns.

What's in the News

Piper Sandler raised its Aflac price target to $125 from $122 and reiterated an Overweight rating, citing favorable claims trends and ongoing tailwinds from normalizing investment income and equity markets (periodicals)
Aflac announced a new partnership with Ameriflex, which will serve as its administrative partner for consumer directed healthcare services in the public sector, enhancing account administration for products such as FSAs and HSAs (key developments)
The company released a new children's book, "Beyond Words," extending its pediatric cancer support initiatives, with 100% of net proceeds going to childhood cancer and blood disorder research through the Aflac Childhood Cancer Foundation (key developments)
Aflac's board approved a first quarter 2026 dividend of $0.61 per share, a 5.2% increase over the prior quarter, reinforcing the insurer's record of returning capital to shareholders (key developments)
From July 1 to September 30, 2025, Aflac repurchased about 9.3 million shares for roughly $1.0 billion, completing a multi year buyback totaling over 258 million shares since 2017 (key developments)

Valuation Changes

Fair Value Estimate edged down slightly from $111.38 to $111.08 per share, indicating a marginally lower intrinsic value assessment.
Discount Rate was effectively unchanged, moving fractionally from 6.956 percent to 6.956 percent, reflecting a stable risk and return profile.
Revenue Growth held steady, ticking up only marginally from 1.42 percent to 1.42 percent, suggesting no meaningful change in top line growth expectations.
Net Profit Margin was effectively flat, inching higher from 20.82 percent to 20.82 percent, implying stable profitability assumptions.
Future P/E eased slightly from 16.38 times to 16.33 times, pointing to a modest reduction in the forward valuation multiple applied to earnings.

Product innovation and digitalization expand Aflac's market reach, support topline growth, and improve operational efficiency and customer engagement.
Investment portfolio diversification and new distribution strategies enhance earnings stability and drive sustained long-term income growth.
Heavy reliance on Japan and challenging investment returns, along with weak U.S. sales growth, pose ongoing risks to Aflac's revenue, earnings, and margin stability.

Catalysts

About Aflac

Through its subsidiaries, provides supplemental health and life insurance products.What are the underlying business or industry changes driving this perspective?

The successful launch of new, customizable cancer insurance (Miraito) in Japan, coupled with strong early sales across all distribution channels-including banks and Japan Post-positions Aflac to capture growing demand for supplemental health coverage among aging and younger consumers, supporting topline revenue and premium growth.
Increased adoption of digital underwriting, customer-facing Gen AI, and digital human avatar initiatives in both Japan and the U.S. is expected to lower long-term operational costs and improve customer engagement, with the potential to materially expand net margins through enhanced efficiency and better scalability.
Heightened consumer awareness of financial health risks and rising medical costs-combined with product innovation (such as modular coverage, new children's cancer policies, and expanded group dental/vision)-broadens Aflac's addressable market and increases cross-sell opportunities, supporting both revenue and persistency.
Ongoing diversification and optimization of Aflac's investment portfolio, including the proactive management of yen
and USD-denominated assets, positions the company to better withstand interest rate cycles and enhance investment income stability, reducing earnings volatility and supporting sustainable bottom-line growth.
Strategic expansion in digital direct-to-consumer channels in the U.S., aggressive agent recruitment in Japan, and new partnerships with large institutions (like state-run disability leave programs) enable Aflac to extend market reach and drive sustained earned premium and fee-based income growth over the long term.

Aflac Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Aflac's revenue will grow by 5.1% annually over the next 3 years.
Analysts assume that profit margins will increase from 15.3% today to 20.4% in 3 years time.
Analysts expect earnings to reach $3.8 billion (and earnings per share of $7.92) by about September 2028, up from $2.4 billion today. The analysts are largely in agreement about this estimate.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 16.7x on those 2028 earnings, down from 23.3x today. This future PE is greater than the current PE for the US Insurance industry at 14.3x.
Analysts expect the number of shares outstanding to decline by 3.73% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 6.83%, as per the Simply Wall St company report.

Aflac Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Net earned premiums in Japan, Aflac's largest and most profitable market, continued to decline year-over-year (down 1.1% excluding one-off effects), and management's guidance recognizes ongoing negative premium growth of -1% to -2% for the foreseeable future, which could constrain future revenue and earnings growth.
The company is experiencing increased technology and expense ratios in Japan (up 280 basis points year-over-year), largely due to digital transformation initiatives; if these investments do not translate into commensurate productivity gains, net margins may remain under pressure.
Aflac's significant exposure to Japan subjects it to persistent currency fluctuations and economic uncertainty-yen depreciation directly impacts reported USD earnings and the efficacy of capital deployment (including 65% of debt held in yen), increasing volatility in both reported revenue and earnings per share.
Variable net investment income was materially below long-term targets in the quarter (down 10.5% in yen terms for Japan), highlighting the ongoing risk from persistent low global bond yields and challenging investment environments, which could lead to lower investment returns and net margins over the long-term.
Persistent sluggishness in U.S. sales (only a 2.7% year-over-year increase), still not at historical growth rates, and dependence on agent recruitment and effectiveness in the traditional distribution channel, points to execution risk; failure to reinvigorate U.S. sales growth may limit future revenue expansion and earnings diversification.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $108.077 for Aflac based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $124.0, and the most bearish reporting a price target of just $99.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $18.5 billion, earnings will come to $3.8 billion, and it would be trading on a PE ratio of 16.7x, assuming you use a discount rate of 6.8%.
Given the current share price of $106.28, the analyst price target of $108.08 is 1.7% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Aflac?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

AFL: Earnings Stability And Strong Buybacks Will Support Balanced Outlook